-
ADVERSE EVENTS IN ROMANIAN HOSPITALS 2017-2024: A NATIONAL LONGITUDINAL ANALYSIS OF NATIONAL AUTHORITY FOR QUALITY MANAGEMENT IN HEALTH - REPORTED INCIDENTS
Aug 11, 2026, 17:16 PM -
TRANSLATING EVIDENCE FROM CONTINUOUS OUTCOMES INTO TRANSITION PROBABILITIES IN MARKOV MODELS: A SYSTEMATIC REVIEW OF CURRENT PRACTICE AND METHODOLOGICAL GAPS IN HEALTH TECHNOLOGY ASSESSMENT
Aug 11, 2026, 17:16 PM -
HEALTHCARE RESOURCE UTILIZATION AND INCIDENCE OF OBESITY-RELATED COMPLICATIONS ACROSS BMI CLASSES: A MULTI-COUNTRY FEDERATED STUDY (COST-O)
Aug 11, 2026, 17:16 PM -
COST-EFFECTIVENESS OF BRENTUXIMAB VEDOTIN IN COMBINATION WITH ETOPOSIDE, DOXORUBICIN, CYCLOPHOSPHAMIDE, DACARBAZINE, AND DEXAMETHASONE (BRECADD) IN NEWLY DIAGNOSED ADVANCED STAGE HODGKIN LYMPHOMA FROM THE ITALY HEALTHCARE PERSPECTIVE
Aug 11, 2026, 17:16 PM -
COST EFFECTIVENESS OF ONASEMNOGENE ABEPARVOVEC IN THE TREATMENT OF PRESYMPTOMATIC SPINAL MUSCULAR ATROPHY IN TURKIYE
Aug 11, 2026, 17:16 PM -
REAL-WORLD DISABILITY AND BURDEN AMONG PATIENTS WITH CHRONIC INFLAMMATORY DEMYELINATING POLYNEUROPATHY
Aug 11, 2026, 17:16 PM -
HEALTHCARE EXPENDITURES ASSOCIATED WITH BODY MASS INDEX IN ADULTS WITH TYPE 2 DIABETES AND ATHEROSCLEROTIC CARDIOVASCULAR DISEASE
Aug 11, 2026, 17:16 PM -
MATCHING-ADJUSTED INDIRECT COMPARISON OF ZILUCOPLAN VERSUS CEMDISIRAN AND GEFURULIMAB IN GENERALISED MYASTHENIA GRAVIS (GMG)
Aug 11, 2026, 17:16 PM -
NAVIGATING JOINT SCIENTIFIC CONSULTATIONS UNDER THE EU HTA REGULATION: STRATEGIC CONSIDERATIONS FOR PARALLEL VERSUS HTA-ONLY ADVICE AND ALTERNATIVE EVIDENCE ALIGNMENT APPROACHES
Aug 11, 2026, 17:16 PM -
DETERMINANTS OF CLINICAL ADDED BENEFIT RATINGS IN FRENCH ONCOLOGY HTA BY HAS: WHAT DIFFERENTIATES ASMR III, IV, AND V ASSESSMENTS?
Aug 11, 2026, 17:16 PM -
VARIATION IN OBESITY BURDEN, MULTIMORBIDITY, AND HEALTHCARE COSTS ACROSS OBESITY CLASS, SEX, AND RACE/ETHNICITY IN THE UNITED STATES
Aug 11, 2026, 17:16 PM -
ECONOMIC IMPACT OF PUBLICLY FUNDED VACCINATION PROGRAMS IN AUSTRIA: RESULTS FROM A FIVE-YEAR BUDGET IMPACT ANALYSIS
Aug 11, 2026, 17:16 PM -
ARE BIOPHARMA DECISIONS BASED ON HIGH-QUALITY RWE? INSIGHTS FROM SLRS
Aug 11, 2026, 17:16 PM -
CAUSAL MACHINE LEARNING FOR HEALTH INSURANCE COVERAGE EFFECTS: FROM INDIVIDUAL TREATMENT EFFECT ESTIMATION TO POLICY OPTIMIZATION USING REAL-WORLD DATA
Aug 11, 2026, 17:16 PM -
CAPTURING PREFERENCE DYNAMICS IN DHT-SUPPORTED OBESITY CARE: A LONGITUDINAL HEALTH PREFERENCE RESEARCH STUDY EMBEDDED IN THE UNIFIED OBESITY USE CASE
Aug 11, 2026, 17:16 PM -
A RAPID APPROACH TO HIGH-VOLUME ABSTRACT SCREENING FOR EXPLORATORY LITERATURE REVIEWS USING BIOMEDICAL TRANSFORMERS
Aug 11, 2026, 17:16 PM -
PERFORMANCE OF ARTIFICIAL INTELLIGENCE (AI) AS A SECOND REVIEWER IN TITLE/ABSTRACT SCREENING: EVIDENCE FROM 30 HEALTH TECHNOLOGY ASSESSMENT-FOCUSED SYSTEMATIC LITERATURE REVIEWS (SLRS)
Aug 11, 2026, 17:16 PM -
REVISITING THE LENGTH OF STAY "SWEET SPOT" AFTER HFREF HOSPITALIZATION USING DAYS ALIVE AND OUT OF HOSPITAL
Aug 11, 2026, 17:16 PM -
THE HEALTH IMPACT OF PEMBROLIZUMAB FOR THE FIRST-LINE TREATMENT FOR PERSISTENT, RECURRENT, OR METASTATIC CERVICAL CANCER (PRMCC) IN TURKIYE
Aug 11, 2026, 17:16 PM -
AMBULATORY CARDIAC MONITORING UTILIZATION AND GUIDELINE ALIGNMENT AMONG SYMPTOMATIC ARRHYTHMIA-NAIVE PATIENTS IN ENGLAND: A REAL-WORLD EVIDENCE STUDY
Aug 11, 2026, 17:16 PM
